...
首页> 外文期刊>Journal of cataract and refractive surgery >One year results of European Multicenter Study of intrastromal corneal ring segments. Part 2: complications, visual symptoms, and patient satisfaction.
【24h】

One year results of European Multicenter Study of intrastromal corneal ring segments. Part 2: complications, visual symptoms, and patient satisfaction.

机译:欧洲多中心基质角膜内环段研究的一年结果。第2部分:并发症,视觉症状和患者满意度。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To assess intraoperative and postoperative complications, visual symptoms, and patient satisfaction after implantation of intrastromal corneal ring segments (ICRS, KeraVision, Inc.) for the correction of myopia and to demonstrate the reversibility and adjustability of refractive corrections with this method. SETTING: Twelve European investigational sites. METHODS: Patients with myopia of -1.0 to -6.0 diopters (D) were assigned to receive 1 of 5 ICRS thicknesses (0.25, 0.30, 0.35, 0.40, or 0.45 mm). Complications and visual symptoms were noted, and patient satisfaction was assessed at each postoperative visit (1 and 7 days and 1, 2, 3, 6, and 12 months). Refractive data were assessed after removal or exchange of the ICRS. RESULTS: Of 163 eyes of 110 patients enrolled, 159 eyes of 107 patients were implanted with an ICRS (52 patients had bilateral implantation). Intraoperative complications occurred in 2% of eyes (4/163 eyes in 3 patients) that were withdrawn from the study: 3 eyes had anterior surface perforations and 1 had a posterior microperforation into the anterior chamber. Most patients had no visual symptoms at 12 months; symptoms usually occurred rarely or sometimes and were mild in severity. At 12 months, good or excellent patient satisfaction was reported for 94% of eyes. Twelve ICRSs (8%) were removed, mainly because of undercorrection and induced astigmatism, and 2 were exchanged. All eyes were within +/-1.00 D of the preoperative manifest refraction spherical equivalent. CONCLUSIONS: The ICRS was safe for correction of low to moderate myopia. Severe postoperative visual symptoms were rare, and patient satisfaction was high. The refractive correction was largely reversible.
机译:目的:评估植入角膜内角膜环段(ICRS,KeraVision,Inc。)矫正近视后的术中和术后并发症,视觉症状和患者满意度,并证明这种方法可逆性和屈光矫正的可调节性。地点:十二个欧洲研究地点。方法:将近视度数为-1.0至-6.0屈光度(D)的患者分配为接受5种ICRS厚度中的1种(0.25、0.30、0.35、0.40或0.45 mm)。记录并发症和视觉症状,并在每次术后访视(1和7天以及1、2、3、6和12个月)评估患者满意度。在移除或更换ICRS后评估屈光数据。结果:110例患者的163只眼中,107例患者的159只眼中植入了ICRS(52例患者进行了双侧植入)。从研究中撤出的眼球占术中并发症的2%(3例中的4/163眼):3眼有前表面穿孔,1眼有前微孔进入前房。大多数患者在12个月时没有视觉症状。症状通常很少或有时出现,并且轻度严重。据报道,在12个月时,有94%的眼睛对患者的满意度良好。移除了十二个ICRS(占8%),主要是由于矫正不足和诱发的散光,并更换了2个。所有眼睛均在术前明显屈光球当量的+/- 1.00 D之内。结论:ICRS对于矫正中低度近视是安全的。严重的术后视觉症状罕见,患者满意度很高。屈光矫正在很大程度上是可逆的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号